ISCDD Celebrates 15th Anniversary of Improving CNS Drug Development Through Collaboration Amongst Stakeholders

Wednesday, March 22, 2017 General News
Email Print This Page Comment
Font : A-A+

LAS VEGAS, March 22, 2017 /PRNewswire/ -- The International Society for CNS Drug Development (ISCDD) is celebrating its 15th

anniversary at the ISCDD 2017 Annual Meeting, March 22nd—24th, in Las Vegas, Nevada.  For 15 years, the ISCDD, a non-profit, independent society, has brought together
the leading CNS drug developers, along with academic and regulatory leaders, to improve CNS drug development.

In celebration of its 15th anniversary, the ISCDD is hosting several special events at the Annual Meeting.  These include a special ISCDD Drug Developers Studio featuring previous ISCDD award winners Antony Loebel, Sunovion Pharmaceuticals, Raymond Sanchez, Otsuka Pharmaceutical, Steve Romano, Mallinckrodt Pharmaceuticals, Jay Kranzler, Regenovation, and chaired by Dr. George Garibaldi, the Chairman of the ISCDD Executive Committee, and Dr. Amir Kalali, Executive Secretary, ISCDD, as well as an Investor Roundtable, and a special session on future technologies.

"For fifteen years, ISCDD has brought together a team of selfless and thoughtful influencers of CNS therapy development," Dr. George Garibaldi said of the occasion of the 15th anniversary.  "Our strategic focus is to enable the discovery and development of novel therapies to patients suffering from brain disorders. I believe that the society has continuously played a significant role in shaping the present and future of health care."

Dr. Amir Kalali said, "Fifteen years ago, when a group of us founded ISCDD, the concept of scientific collaboration was a novel one in the pharmaceutical industry.  We believe strongly that pre-competitive collaboration helps us bring treatments to patients faster and more efficiently.  It has been a pleasure to witness the spirit of collaboration for the good of our patients grow throughout our history."

The International Society for CNS Drug Development (ISCDD) is a non-profit, independent leadership forum founded in 2002 to improve central nervous system drug development through collaboration amongst stakeholders including industry, academia, and government.

For more information, please contact:

Erica Moore ISCDD Secretariat O: 702-992-0784 M: 610-613-3524 151660@email4pr.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/iscdd-celebrates-15th-anniversary-of-improving-cns-drug-development-through-collaboration-amongst-stakeholders-300427659.html

SOURCE ISCDD



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook